And recently, JD Vance confirmed that Musk has Social Security in his crosshairs. Americans didn’t vote to cut Social Security and Medicare. Nor for higher drug prices. In fact,

In total, The Washington Post identified 31 major campaign promises Trump pledged for his second term. Here are some of the most consequential steps Trump has said he’ll take as president.

Like most elected officials, Donald Trump recognizes that Social Security is vital to the financial well-being of our nation's retirees. But he's not oblivious to the fact that altering Social Security comes with potentially negative ramifications. While speaking at the Conservative Political Action Conference in March 2013, Trump said:

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that will be negotiated directly between the government and drug manuf

Education: Trump’s proposals for K-12 schools include having parents elect school principals, cutting federal funding to any school teaching “critical race theory,” ending t

Groups representing employers that offer health insurance are gearing up to defend and try to bolster the largest source of health coverage for people under 65 in the U.S.

Retirees could feel the economic impact of President-elect Donald Trump prepares to reclaim office in Washington, DC. In his first term, Trump completely redefined economic policy with corporate

Biden's administration announced weight loss drugs Ozempic and Wegovy will be included on Medicare's list of medications subject to direct price negotiations.

House Speaker Mike Johnson said cuts to Social Security and Medicare won't be part of the legislative plan being worked out to fund President-elect Donald Trump's agenda.

President-elect Donald Trump faces deep skepticism that his administration's policies will make health care more affordable, a new Gallup poll says.

Announcing the 15 medicines chosen for the second round of negotiations is one of the Biden administration’s final health policy acts.

Biotech stocks have slumped 15% since Donald Trump won his second presidency. That's because Trump comes with a lot of unknowns.